Crocus Sativus Extract Impact in Metabolic Control of Patients With Diabetes Mellitus Type 1
Diabetes Mellitus, Type 1, Diabetes type1
About this trial
This is an interventional treatment trial for Diabetes Mellitus, Type 1 focused on measuring diabetes mellitus type 1, diabetes type 1, saffron, saffron extract, continuous glucose monitoring
Eligibility Criteria
Inclusion Criteria: People with diabetes mellitus type 1 (with diabetes duration over 1 year) (adults <18 years old) wearing a continuous glucose monitoring system with or without an insulin pump Exclusion Criteria: Pregnant People with diabetes mellitus type 2 Breastfeeding women People with liver disease People with chronic kidney disease (over stage 3) People with allergy in crocus sativus People that consume everyday herbs or supplements People on anti platelet treatment not for prevention
Sites / Locations
- University General Hospital of Thessaloniki AHEPA
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Active Group
Placebo group
A sachet of a combination of 4 strains of probiotics (1billion CFU) (Lactobacillus rhamnosus, Bifidobacterium animalis lactis, Bifidobacterium breve, Bifidobacterium longum), Fructooligosaccharides 100mg, Magnesium 75mg and Crocus sativus (Saffron extract 28mg) was administered 3 times per day in people with diabetes type 1 for 6 months on continuous glucose monitoring systems.
A sachet of a combination of 4 strains of probiotics (1billion CFU(Lactobacillus rhamnosus, Bifidobacterium animalis lactis, Bifidobacterium breve, Bifidobacterium longum), Fructooligosaccharides 100mg, Magnesium 75mg without crocus sativus was administered 3 times per day in people with diabetes type 1 for 6 months on continuous glucose monitoring systems.